Immunic, Inc. · NASDAQ:IMUX
Soleus Capital Master Fund, L.P.'s stake in Immunic, Inc. fell to 4.90% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
Soleus Capital Master Fund, L.P.'s stake in Immunic, Inc. fell to 4.90%, 679,200 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 679,200
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Capital Master Fund, L.P. | 4.90% | 679,200 |
| Soleus Capital, LLC | 4.90% | 679,200 |
| Soleus Capital Group, LLC | 4.90% | 679,200 |
| Soleus Capital Management, L.P. | 4.90% | 679,200 |
| Soleus GP, LLC | 4.90% | 679,200 |
| Guy Levy | 4.90% | 679,200 |
Source
Related
- Immunic, Inc.
- Soleus Capital Master Fund, L.P.
- Immunic, Inc. shareholders
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · Millennium Management LLC · Aug 6, 2026
- Schedule 13G · Laurion Capital Management LP · Aug 4, 2026
- Schedule 13G/A · Aberdeen Group plc · Jul 16, 2026